🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07552532
Active, not recruiting Observational

Multimodal CT-Based Risk Stratification for Postoperative Local Recurrence in NSCLC: A Multicenter Study

NCT07552532 · tracked via the Priya Life Science China tracker
Sponsor
Guangming Lu
Phase
Observational
Started
2023-01-01
Last updated
2026-04-27

Condition(s) studied

Lung Cancer (NSCLC)

Study summary

This multicenter retrospective study is designed to develop and validate a CT-based multimodal risk stratification approach for postoperative local recurrence after curative-intent resection of non-small cell lung cancer (NSCLC). The approach integrates clinicopathologic variables, intratumoral and peritumoral radiomics, tumor-based 2.5D deep learning features, whole-lung deep learning features, and operative text features to capture complementary information related to tumor phenotype, pulmonary background, and surgical findings. Predictive performance and clinical utility will be evaluated in internal and external validation cohorts using the concordance index, time-dependent area under the receiver operating characteristic curve, decision curve analysis, and risk reclassification analyses. The objective of this study is to assess whether multimodal CT-based risk stratification may improve postoperative risk assessment and support individualized surveillance and management strategies.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Pathologically confirmed non-small cell lung cancer (NSCLC) 2. Preoperative contrast-enhanced chest CT performed within 2 weeks before surgery 3. Underwent routine postoperative follow-up Exclusion Criteria: 1. Small cell lung cancer or metastatic tumors 2. Incomplete resection (R1/R2) 3. No preoperative contrast-enhanced CT performed within 2 weeks before surgery 4. History of other malignancies 5. Inadequate follow-up or follow-up duration of 3 months or less

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Jinling Hospital Nanjing Jiangsu

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07552532 on ClinicalTrials.gov ↗ ← All trials in China